Australian study first ever to use CAR T-cells to prevent relapse after treatment
In a world first, the Australian COMMITTAL trial uses CAR T-cell therapy to improve survival for people with B-cell ALL who have an allogeneic stem cell transplant.
- Acute lymphoblastic leukaemia
- Research
- Treatments and side-effects
